Meyer Andrew Hollman sold JANX
November 14, 2025 · Form 4 insider transaction
Meyer Andrew Hollman sold 3,333 shares of Janux Therapeutics, Inc. at $30.00 per share, a transaction worth $100.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,333
Price
$30.00
Total value
$100.0K
InsiderMeyer Andrew Hollman
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 14, 2025
Filing dateNovember 14, 2025
Shares owned after84,974
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024.